Aggressive antiplatelet therapy reduces the risk of coronary stent thrombosis associated with the GPIIb/IIIa PLA2 polymorphism

被引：0
|
作者：
Walter, DH [1 ]
Elsner, M [1 ]
Goette, S [1 ]
Auch-Schwelk, W [1 ]
机构：
[1] Univ Frankfurt, D-6000 Frankfurt, Germany
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3744
引用
收藏
页码：709 / 710
页数：2
相关论文
共 40 条
  • [31] The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with the risk of type 2 diabetes. The Ludwigshafen Risk and Cardiovascular Health Study
    W. März
    B. O. Boehm
    B. R. Winkelmann
    M. M. Hoffmann
    Diabetologia, 2004, 47 : 1969 - 1973
  • [32] PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran
    Pourgheysari, Batoul
    Boroujeni, Hamid Rouhi
    Hasheminia, Ali Mohammad
    Drees, Fatima
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (05) : 471 - 476
  • [33] Statin therapy abrogates increased restenosis rates following coronary stent implantation in carriers of the glycoprotein IIb/IIIa receptor polymorphism PIA2
    Walter, DH
    Mach, S
    Auch-Schwelk, W
    Elsner, M
    CIRCULATION, 1999, 100 (18) : 466 - 466
  • [34] Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients
    Gardemann, A
    Humme, J
    Stricker, J
    Nguyen, QD
    Katz, N
    Philipp, M
    Tillmanns, H
    Hehrlein, FW
    Rau, M
    Haberbosch, W
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) : 214 - 217
  • [35] Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the PIA2 allele of the platelet glycoprotein IIIa gene
    Walter, DH
    Schächinger, V
    Elsner, M
    Mach, S
    Dimmeler, S
    Auch-Schwelk, W
    Zeiher, AM
    EUROPEAN HEART JOURNAL, 2001, 22 (07) : 587 - 595
  • [36] PlA2 Polymorphism of Platelet Glycoprotein IIb/IIIa and C677T Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR), but Not Factor V Leiden and Prothrombin G20210A Polymorphisms, Are Associated with More Severe Forms of Legg-Calve-Perthes Disease
    Dolores Garcia-Alfaro, Maria
    Isabel Perez-Nunez, Maria
    Teresa Amigo, Maria
    Arbona, Carmelo
    Angeles Ballesteros, Maria
    Gonzalez-Lamuno, Domingo
    CHILDREN-BASEL, 2021, 8 (07):
  • [37] Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials
    Feng Huang
    BMC Pharmacology and Toxicology, 19
  • [38] Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials
    Huang, Feng
    BMC PHARMACOLOGY & TOXICOLOGY, 2018, 19 : 31
  • [39] Genetic variants besides CYP2C19*2 polymorphism are associated with major adverse cardiovascular events in high risk vascular patients on dual antiplatelet therapy
    Giusti, B.
    Saracini, C.
    Vestrini, A.
    Magi, A.
    Marcucci, R.
    Rossi, L.
    Cordisco, A.
    Nanna, C.
    Gensini, G. F.
    Abbate, R.
    EUROPEAN HEART JOURNAL, 2010, 31 : 156 - 156
  • [40] Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation
    Harmsze, Ankie
    van Werkum, Jochem W.
    Bouman, Heleen J.
    Ruven, Henk J.
    Breet, Nicolien J.
    Ten Berg, Jurrien M.
    Hackeng, Christian M.
    Tjoeng, Mathieu M.
    Klungel, Olaf H.
    de Boer, Anthonius
    Deneer, Vera H.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (01): : 18 - 25
1234